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To evaluate Compass, a new instrument for glaucoma screening and diagnosis that com-
bines scanning ophthalmoscopy, automated perimetry, and eye tracking.
Materials and Methods
A total of 320 human subjects (200 normal, 120 with glaucoma) underwent full ophthalmo-
logical evaluation and perimetric evaluation using the Humphrey SITA standard 24° test
(HFA), and the Compass test that consisted of a full-threshold program on the central 24°
with a photograph of the central 30° of the retina. A subgroup of normal subjects and glauco-
ma patients underwent a second Compass test during the same day in order to study test-
retest variability. After exclusion of 30 patients due to protocol rules, a database was creat-
ed to compare the Compass to the HFA, and to evaluate retinal image quality and
fixation stability.
Results
The difference in mean sensitivity between Compass and HFA was -1.02 ± 1.55 dB in normal
subjects (p<0.001) and -1.01 ± 2.81 dB in glaucoma (p<0.001). Repeatability SD for the av-
erage sensitivity was 1.53 for normal subjects and 1.84 for glaucoma. Test time with the Com-
pass was 634±96 s (607±78 for normals, 678±108 for glaucoma). Compass analysis showed
the percentage of fixation within the central 1° was 86.6% in normal subjects, and 79.3% in
glaucoma patients. Color image quality was sufficient for diagnostic use in>65% of cases;
Image-based diagnosis was in accordance with the initial diagnosis in 85% of the subjects.
Conclusions
Based on preliminary results, Compass showed useful diagnostic characteristics for the
study of glaucoma, and combined morphological information with functional data.
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Introduction
Glaucoma is the leading cause of irreversible blindness with a prevalence of 3.5% in the popula-
tion aged 40–80 years. In 2013, the disease affected 64.3 million people worldwide, and is ex-
pected to increase to 76 million in 2020 and 111.8 million by 2040 [1].
Due to the lack of symptoms up to advanced stages and to the limitations of world-wide di-
agnostic resources and information (so that a high number of subjects are very rarely seen by
ophthalmologists in the course of their life), the current undetection rate for the disease is
about 50%, even in so-called “developed” countries [2–3].
Currently, the diagnosis of glaucoma relies on the assessment of intraocular pressure (IOP)
and its confounding factors, as well as specific changes occurring in the visual field (VF), the
optic nerve head (ONH), and the retinal nerve fiber layer (RNFL).
VF is studied by means of automated perimetry; the most common perimeter used by oph-
thalmologists is the Humphrey Field Analyzer (HFA; Zeiss Humphrey Systems, Dublin, Ca,
USA). Perimetry is commonly considered the diagnostic gold-standard for glaucoma progres-
sion, as it is a reliable test with a very accurate database, which has been validated over many
decades of clinical use. In addition, it enables the detection of small glaucomatous changes,
which directly impact the visual function of patients. Yet, perimetry is limited by low diagnostic
sensitivity in early stages of the disease.[4], and being a psychophysical test, it is also influenced
by learning, fatigue, psychophysical status, as well as eye movements. [5]
The use of microperimetry [6], of more accurate perimetric grids, [6] unconventional peri-
metry [7] and high-tech instruments to assess the thickness of the ONH and RNFL (in particu-
lar by means of Optical Coherence Tomography, OCT) [8] may be helpful in early diagnosis.
Recent studies indicate that integration of morphological and functional data could strongly
enhance glaucoma diagnostic ability [8–9]. The study of fixation may be also of interest for two
reasons: it affects the quality of VF tests, and it is abnormal in both early and advanced glauco-
ma stages compared with controls. [10–11]. Finally, telemedicine could provide a valid help in
diagnosing glaucoma on subjects who do not attend regular eye visits. [12]
The aim of this study was to evaluate a new instrument, called Compass (CenterVue, Pa-
dova, Italy), which is a fully automated device consisting in a scanning ophthalmoscope (col-
lecting live infrared images of the fundus and color images of the posterior pole without pupil
dilation) combined with an automated perimeter and an eye tracker (allowing the study of fixa-
tion stability and the accurate presentation of stimuli at predefined retinal locations, thanks to
the active compensation of eye movements / fixation losses). Being Compass data easily acces-
sible via Internet, the instrument may play a role in teleglaucoma. For this study we used a 24°,
full-threshold perimetric strategy; customized and adaptive perimetric grids are being devel-
oped to increase the diagnostic accuracy and reduce test time.
Methods
This study was conducted at the Eye Clinic of San Paolo Hospital, University of Milan, Italy,
from November 2013 to June 2014. It was approved by the “San Paolo Hospital Ethics Com-
mittee” (n. 734 of July 30th, 2013—Studio GSD 2013). It followed the requirements of the Hel-
sinki declaration, the guidelines on Good Clinical Practice (GCP). and of the International
Conference on Harmonization (ICH). All participants gave their written informed consent.
Study objectives were:
• to compare perimetric data measured by Compass and HFA in patients with glaucoma and
normal subjects;
• to generate a first version of a normative database for Compass;
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• to measure test-retest variability of Compass perimetric data;
• to evaluate the quality of images of the retina obtained by Compass;
• to explore fixation stability in normal and glaucoma subjects.
The study protocol was open label and cross-sectional. It consisted of one visit to verify in-
clusion and exclusion criteria, and to then perform the study tests. Examinations consisted of
full ophthalmological evaluation; perimetric demonstration in patients inexperienced with
perimetry; one HFA test using Standard Swedish Interactive Threshold Algorithm (SITA) stan-
dard strategy over central 24°; one Compass test using a conventional full threshold strategy
(4–2 staircase, modeled on accelerated stochastic approximation) on the central 24°; a photo-
graph of the central 30° (radius) of the retina with Compass; RNFL OCT evaluation; and red-
free and infrared imaging of the retina and optic nerve head. A subgroup of normal subjects
and glaucoma patients underwent a second Compass test during the same day with the same
operator in order to study test-retest variability.
The study was conducted on both normal subjects and glaucoma patients, on one eye per
patient, chosen at random. The sequence of perimetric tests was randomized. A 30-minute in-
terval was observed between any two tests. In the case of an unreliable test (fixation losses, or
false positive or false negative> 30%), an attempt was made to repeat the test. if the second test
was also unreliable, the patient was excluded from the study.
Inclusion criteria for normal subjects were: age between 20 and 80 years; best-corrected dec-
imal visual acuity>0.8 (for subjects<50 years old) or>0.6 (over 50) in both eyes; spherical re-
fraction within ±5D; astigmatism within ±2D; normal visual field in both eyes (normal mean
deviation, MD, and pattern standard deviation, PSD); normal appearance of the optic disc in
both eyes; and an IOP 21 mmHg in both eyes. Inclusion criteria for glaucoma subjects were:
age between 20 and 80 years; best-corrected visual acuity>0.8 (for subjects<50 years old) or
>0.6 (over 50) in both eyes; spherical refraction within ±5D; astigmatism within ±2D; the ap-
pearance of a glaucomatous optic disc in both eyes (a diffuse neuroretinal rim narrowing with
concentric enlargement of the optic cup or localized notching, or both); and IOP>22 mmHg
in both eyes in subjects without treatment or<21 mmHg in treated subjects. Exclusion criteria
for all subjects were: refusal to participate in the study; presence of ocular pathologies other
than glaucoma; evidence or a history of ocular trauma or ocular surgery (except for cataract
surgery without complications) in both eyes; the presence of pathologies which may interfere
with visual field testing; and the use of drugs which may interfere with visual field testing.
Investigational hypotheses for this study are summarized in Table 1.
Table 1. Investigational hypotheses.
1) Comparison with
HFA
The two devices should provide equivalent results on normal subjects and
glaucomatous subjects (average differences within ±2 dB)
2) Normative
database
A decrease in sensitivity with age of approximately 0.05 dB per year, as well as a
decrease with increasing eccentricity should be shown




It shall be possible to obtain good quality color images on at least 85% of the
subjects presenting with a minimum pupil diameter of 3.0 mm
5) Examination time Average examination time for 24–2 test with 4–2 threshold strategy shall not
exceed the time required for a similar test with HFA
6) Failure rate The number of subjects for which the test fails, for various reasons, should be
comparable with those failing on HFA
doi:10.1371/journal.pone.0122157.t001
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The Compass unit is shown in Fig. 1. The instrument is 62 cm x 59 cm x 36 cm and includes
a perimeter, a scanning ophthalmoscope, an eye tracker to measure fixation and to actively
compensate for eye movements during examination.
Compass procedure
The test is performed in a dark room. After patching the fellow eye, the patient is asked to
place his or her forehead against the bar and the chin on the rest. No corrective lenses are re-
quired, as the system automatically corrects for spherical aberration and focuses on the retina
to compensate for refractive error. Fixation is first evaluated, then VF test is performed with a
double control for fixation: a continuous, live infrared image of the retina (available on the op-
erator pad), and an automatic eye tracker. At the end of the procedure, a color image of the ret-
ina is collected.
Compass as a perimeter. In the current version (software version 0.2), the device evaluates
the retinal sensitivity using the following characteristics: 24–2 grid (54 locations spaced by 6
degrees), threshold strategy: 4–2 staircase modeled on accelerated stochastic approximation,
stimulus size: Goldmann III, stimulus duration: 200 msec, background luminance: 31.4 asb,
maximum luminance: 10,000 asb. As continuous control of fixation is made during the Com-
pass test, a “fixation loss” index (which is present in the HFA) is not recorded.
Compass to evaluate fixation stability. Compass acquires live infrared images of the fun-
dus at 25 frames per second. These are processed to identify multiple retinal landmarks and
track their movements. By means of this technique, the instrument provides a measure of a pa-
tient’s fixation characteristics, with accuracy of about 20 microns (being 17 microns Compass
imaging resolution).
Fixation stability was quantified as follows:
• the average X-Y coordinate of all fixation points (Pi) was calculated (= center of fixation);
• the Cartesian distance (in degrees) of all fixation points from fixation center (Di) was
determined;
Fig 1. Compass automated fundus perimeter, with tablet and joystick interface.
doi:10.1371/journal.pone.0122157.g001
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• the percentage of points having distance Di< 1° (P1) was reported as a measure of stability.
Differently from the HFA (which just records pupil movements), real time retinal tracking
allows Compass to actively compensate for eye movements throughout the VF test. This is
done by recalculating a stimulus position before it is actually presented, based on the current
position of the retina: this compensation mechanism is key to maximize the test reliability, as
illustrated in Fig. 2.
Thanks to the retinal tracker, the position of stimulus projection is compensated for minor
eye or head movements, i.e. the instrument actively ensures that any stimulus is projected ex-
actly at its programmed retinal location, regardless of fixation losses. In case of major move-
ments, resulting in a lost tracking, projection is paused until the retina is tracked again.
Compass as a scanning ophthalmoscope. The Compass instrument collects images of the
central retina over a 30° radius field, obtained using infrared or white light sources to illumi-
nate the retina, by means of a confocal setup, using a 5 megapixel (Mp) sensor. The instrument
is intended to provide retinal images of sufficient quality for a pupil diameter of 3 mm or more;
therefore, no dilation is necessary for most subjects. The instrument does not measure pupil
size in the current version.
Fig 2. Eye tracking compensation. (A) The green dot shows the expected presentation position on the
retina of one of the 24–2 measurement locations. (B) The red dot shows the actual presentation position in
presence of a 3-degree eye movement at the time of presentation (see arrow) and in absence of a
compensation mechanism: the red dot is where the HFA would actually measure sensitivity, without a chance
to time-correlate presentation of this stimulus with the information provided by the gaze tracker. The use of a
25 Hz retinal tracker instead, enables Compass to maintain the expected presentation position even in
presence of wide and fast eye movements.
doi:10.1371/journal.pone.0122157.g002
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Data management
A total of 350 subjects were recruited, with 30 subjects excluded for the following reasons: ten
subjects had either Compass or HFA tests outcomes that were clinically judged as unreliable
(Compass: 2 cases; HFA: 6 cases, both devices: 2 cases); one subject had an uncertain diagnosis;
two subjects had previously undetected co-morbidities (1 with macular edema, 1 with angle-
closure glaucoma); and 17 subjects did not complete all parts of the protocol.
Three normal subjects (1.5%) in the Compass dataset and 1 subject (0.5%) in the HFA data-
set were classified as outliers (average retinal sensitivity below 3 standard deviations from the
mean), and excluded from further analyses. All subjects with glaucoma were considered.
Statistical analysis
For perimetric comparative analysis, VF sensitivities of left eyes were converted to a stimulus
location grid as if they were right eye cases. Locations corresponding with the blind area of the
ONH were excluded from the analysis of both instruments. Recorded test times included auto-
focus to correct spherical aberration, tracking, the VF test, and retinal imaging.
Images were graded as follows. Score-1 (missing picture). Score 0 (insufficient quality): reti-
na not visible or ONHmargins not entirely visible. Score 1 (sufficient quality): RNFL partially
invisible, or image partially defocused, or image slightly over- or under-exposed. Score 2 (good
or excellent quality): fully visible retina, correct focus, and illumination.
Fixation rate was analyzed by considering the percentage of fixation points within 1° from
the center of mass of all fixation points recorded during the perimetric test (P1) [13].
Normal and glaucoma subjects were compared with t-test for unpaired data. Coefficient of
variation (CV) was obtained by dividing mean repeatability for each group by the respective
threshold means in the groups. Bland-Altman plots of the locations within 10° were calculated
in order to allow a comparison with the HFA from previously published literature data. [14]
Results
The main characteristics of the subjects who completed the study are given in Table 2. The rela-
tive case distributions per decade of age of the 197 normal subjects whose tests were used to
generate the normative database were: 13% (decade 20–29), 8% (30–39); 23% (40–49); 26%
(50–59); 20% (60–69); 9% (70–79).
Comparison with HFA
Mean sensitivity for normal subjects was 28.5 ± 1.6 dB for Compass and 29.5 ± 1.8 dB for HFA
and the difference between the two measurements was-1.02 ± 1.55 dB (p<0.001). Mean
Table 2. Characteristics of the study population.
Total Normal Glaucoma
Age, years, mean ± sd (range) 58.5 ± 16.7 (20–86) 50.6 ± 15.2 (20–86) 71.8 ± 8..8 (34–86)
Race, number 320 200 120
Caucasian 319 200 119
Hispanic 1 0 1
Right / Left, number 188 / 132 119 / 81 69 / 51
Female / Male, number 185 / 135 127 / 73 58 / 62
Best-corrected visual acuity 0.93±0.21 0.96±0.07 0.88±0.33
doi:10.1371/journal.pone.0122157.t002
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sensitivity for glaucoma subjects was 21.2 ± 7.1 dB for Compass and 22.2 ± 6.6 dB for HFA and
the difference between the two measurements was-1.01 ± 2.81 dB (p<0.001).
Mean retinal sensitivities obtained with both devices at each stimuli location on normal sub-
jects are presented in Fig. 3.
Standard deviations of sensitivities obtained with both devices at each stimuli location on
normal subjects are shown in Fig. 4.
Database
The formulas of global linear regression equations yielding Normal Sensitivity (NS) as a func-
tion of age were:
ðCompassÞ NS ¼ 0:04  Ageþ30:8 ðp < 0:001; r2¼ 0:17Þ
ðHFAÞ NS ¼ 0:06  Ageþ32:7 ðp < 0:001; r2 ¼ 0:28Þ
Fig 3. Mean retinal sensitivity at each location for Compass (A), HFA (B), and their difference (C).
doi:10.1371/journal.pone.0122157.g003
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The reduction of retinal sensitivity induced by age in normal subjects was studied additionally
on foveal and perifoveal regions (average of fovea and four central locations) and on the central
10°. For Compass, the mean decrease was -0.048 dB / year for the foveal and perifoveal areas,
and -0.045 dB / year for the central 10°. For HFA, other published sources report a mean de-
crease of-0.047 dB / year for the foveal area [15] and of-0.041 dB / year for the central 10° [14].
Independent linear regression equations were derived for each stimuli location, providing
an estimate of NS at any grid location, for any specific age. The inferior limit for normal sensi-
tivity at a certain location (x, y) for a subject of a given age was calculated as follows:
INF ðx; y; aÞ ¼ NS ðx; y; aÞ -2 SD ðx; y; aÞ
where SD(x, y, a) is the standard deviation of normal sensitivity at location (x, y) for the age
group corresponding to a.
A decrease of sensitivity was observed as a function of eccentricity, as expected. This was
checked by calculating NS along certain meridians and parallels belonging to the 24–2 grid, for
a certain age using the above mentioned point-wise linear regression equations. Such values ex-
hibited a good fit with 2nd order polynomial functions (data not shown), suggesting parabolic
behaviors in space, with vertices in the foveal region and decreasing values with
increasing eccentricity.
Compass test-retest variability
A subset of 89 normal subjects (age: 49.6 ± 13.1, range: 20–73 years) and 19 subjects with glau-
coma (age: 72.2 ± 8.2, range: 48–81 years) were tested twice with Compass for
precision analysis.
For normal subjects, average sensitivity was 29.2 ± 1.5 dB at the first test, and 29.4 ± 1.4 dB
at the second test (p = 0.014). For glaucoma patients, average sensitivity was 25.0 ± 4.7 dB at
the first test, and 24.5 ± 5.0 dB at the second test (p = 0.011).
A Bland-Altman plot for the global sensitivity at test-retest on normal subjects is given on
Fig. 5. The horizontal solid line represents the mean difference (+0.2 dB) and the dotted lines
represent the 95% limits of agreement between measurements (-1.3 / +1.7 dB).
Repeatability SD for the average sensitivity with the Compass was 1.53 for the Normal
group and 1.84 for the Glaucoma group (Table 3). These values correspond to a CV of 0.05 and
0.07 respectively.
A Bland-Altman plot of the locations within 10° is given in Fig. 6: the mean difference was
+0.1 dB, and the 95% limits of agreement were-1.5 / +1.6 dB.
Fig 4. Retinal sensitivity standard deviations at each location in normal group for Compass (A) and
HFA (B).
doi:10.1371/journal.pone.0122157.g004
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Compass retinal imaging
During perimetry, live infrared images were of adequate quality in 85% of the cases and permit-
ted the visualization of the fundus during perimetry and operation of the retinal tracker in
100% of the cases.
Color images, obtained at the end of the procedure, were evaluated. 93 subjects (29.1%) had
a score of-1; 20 (6.3%) of 0; 73 (22.8%) of 1; and 134 (41.9%) of score 2. It was therefore possi-
ble to obtain useful (score>0) color images of the central 30° of the retina in approximately
70% of the subjects. Reasons for failure or insufficient quality included: pupil too small; eccen-
tric fixation; subject moved away from device; poor device alignment; image out of focus; dirt
on front lens; image too dark / too bright; and eye lids closed.
Examples of fundus images are given in Fig. 7.
Morphological vs functional data
In order to correlate structural and functional information yielded by Compass, we derived a
clinical diagnosis (normal or glaucoma) for all study subjects solely based on the acquired color
retinal images, as a method for structural assessment of the optic disc. Then we did the same
Fig 5. Bland-Altman plot for mean sensitivity (2nd—1st measurement) for normal subjects
undergoing test-retest analysis. x, average of mean sensitivity of the two tests (dB). y, difference of mean
sensitivity of the two tests (dB).
doi:10.1371/journal.pone.0122157.g005
Table 3. Compass repeatability: SD for Average sensitivity and individual stimuli sensitivities.
Group/Parameter Repeatability
Normal (N = 89) Average Threshold Repeatability SD 1.53 dB
Maximum Individual Stimulus Repeatability SD 2.20 dB
95% Percentile Individual Stimulus Repeatability SD 1.98 dB
Glaucoma (N = 19) Average Repeatability SD 1.84 dB
Maximum Individual Stimulus Repeatability SD 2.68 dB
95% Percentile Individual Stimulus Repeatability SD 2.33 dB
doi:10.1371/journal.pone.0122157.t003
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independently with red-free images, which provide information about the RNFL. The two clin-
ical evaluations were made by an experienced grader and then combined together (“combined
morphological diagnosis”), which was compared with the initial one. 319 subjects were consid-
ered for this analysis. The agreement with the initial diagnosis was 86.6% for colour images,
82.3% for red-free images, and 87.2% for the combination. Considering the combined diagno-
sis, the cases of disagreement received a morphological diagnosis of glaucoma in 2.5% of cases,
and a morphological diagnosis of normality in 10.2% of cases.
Compass test time
The average examination time with Compass on all study subjects was 634 ± 96 s per eye. The
time was 607 ± 78 s for normal subjects, and 678 ± 108 s for glaucoma patients. The average ex-
amination time with HFA (SITA standard) on all study subjects was 309 ± 61 s per eye. The
time was 294 ± 44 s for normal subjects, and 358 ± 65 s for glaucoma patients.
Compass fixation analysis
Fixation rate within the central 1° was 86.6% in normal subjects, and 79.3% in glaucoma pa-
tients (5th percentile was 48.9% and 31.0% respectively).
Usability of the Compass device
Overall, the patients found the test easy to perform. The only adverse event (device-related)
was excess lacrimation in about 5% of subjects. Compliance to protocol was excellent.
Discussion
This pilot study aimed at exploring the diagnostic performance of Compass, a new device for
glaucoma diagnosis and follow-up. This instrument is both a perimeter and a scanning oph-
thalmoscope. It also contains an eye tracker that enables the study of position and stability of
Fig 6. Bland-Altman plots for mean sensitivity of the central 10° (2°– 1° measurement), normal group.
x, average of mean sensitivity of the two tests (dB). y, difference of mean sensitivity of the two tests (dB).
doi:10.1371/journal.pone.0122157.g006
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fixation (which have been found to be relevant for glaucoma [10,11]) and the active control of
locations at which stimuli are presented.
In the management of glaucoma, perimetry plays a key role. As a consequence, the primary
objectives of this study were to explore Compass validity as a perimeter in comparison with the
Fig 7. Examples of color images: normal subject (A), glaucoma patient (B), optic nerve head detail (C), infrared image with a sensitivity grid (D).
doi:10.1371/journal.pone.0122157.g007
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currently accepted clinical standard (i.e., the HFA 24° SITA Standard), and to generate a nor-
mative database for Compass perimetry.
The instrument fulfilled all the perimetric hypotheses outlined in Table 1
concerning perimetry.
The point-to-point sensitivities calculated over a 24° grid were comparable for Compass
and HFA both in normal and glaucoma subjects, as a difference of +1.0 dB was found in both
study groups, with HFA measuring higher than Compass. We postulate that Compass provid-
ed lower threshold measurements than HFA due to the different thresholding algorithm. In
fact SITA standard is known to slightly overestimate threshold vs. full-threshold testing [16].
Another possible source of reduced sensitivity with Compass is fatigue effect; in the current
version, perimetric test time is in fact longer than SITA. Yet, the difference was largely within
acceptable clinical limits.
The database showed solid characteristics: a trend for a decrease in sensitivity with age of
approximately 0.05 dB per year was found, as well as a decrease in sensitivity with increasing
eccentricity of the stimulus location. A larger normative database is needed to further differen-
tiate the lower-than-normal results. In particular the sub-category of patients above the age of
70 (where the majority of glaucoma patients occur) is not yet adequately represented.
In addition, precision of the Compass device was good: average SD was 1.53 dB for normal
subjects, and 1.84 for glaucoma. In the second examination sensitivity was found to be slightly
higher compared to the first one in normal subjects (29.2 vs 29.4 dB), but not in glaucoma pa-
tients (25.0 vs 24.5 dB). This may be due to a mild learning effect. A mean test-retest difference
of +0.2 dB was found on the whole population; the 95% limits of agreement between overall
global sensitivity were-1.3 dB and +1.7 dB.
Precision of the Compass was not directly compared with the HFA in this study. Still, in
order to allow comparison with literature data, we built a Bland-Altman plot for central 10° lo-
cations, and we found that the Compass 95% limits of agreement were approximately 20% nar-
rower than the HFA’s (-1.5 / +1.6 dB, compared with*±2 dB for HFA), suggesting that
Compass had a reduced variability compared to HFA [10]. Considering that Compass’ current
threshold strategy is less favorable than SITA standard, we postulate that such an advantage
may be due to retinal tracking, allowing a precise stimulus presentation on the tested locations.
The quality of infrared images was satisfactory in 85% of the cases and allowed the visualiza-
tion of the fundus during perimetry and operation of the retinal tracker in 100% of the cases.
An infrared image has an advantage to better identify the optic disc and cup margins. Color
images could be obtained in 65% of cases; quality was good or excellent in 42%, sufficient in
23%, and insufficient in 9%. In 35% of cases, a color image could not be collected for the causes
listed in the Results section; mainly it was due to most patients moving away from the instru-
ment at the end of perimetry or closing their eyelids, which are errors attributed to unfamiliari-
ty of the device by the patient. Further developments of the test procedure are in progress,
which should allow for a significant reduction of the percentage of failure, e.g., a vocal message
to remind the patient to stay still and open the eyelids as the image is collected. It is also possi-
ble to collect retinal images without performing the complete procedure of perimetry
+ imaging.
ONH and RNFL images confirmed the perimetric diagnosis in about 85% of cases, with no
differences between ONH and RNFL. In just 2.5% of cases, imaging suggested a diagnosis of
glaucoma. It should be noted that this analysis was based on HFA and not on Compass perime-
try (being MD and PSD extrapolated after the creation of a database). These results on the cor-
relation between morphology and function are preliminary and deserve validation on properly
designed studies.
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Examination time with Compass (634 seconds) was longer than SITA Standard and compa-
rable with full-threshold HFA. The adoption of a database and of different threshold strategies,
and the use of different grids will guarantee a significant reduction of test time in the future
versions of the software. Of note, the test time with Compass covers a larger span of events (au-
tofocus, VF test with tracker, imaging) than HFA (just perimetry alone). In addition, the time
used to refract the patient and align corrective lenses is not considered in the comparison to
the HFA.
Finally, failure rate in the study was 1% (four subjects), which was comparable with the
HFA failure rate.
Overall, the multi-function Compass device may provide a number of possible advantages
over single function perimetric assessment device, such as the HFA.
Major advantages over HFA include the smaller physical size of the instrument, the possibil-
ity of having the eye tested without near correction; lower test variability probably due to the
increased repeatability in a stimulus projection location by means of live retinal tracking; and
the possibility of developing an ad-hoc grid pattern to reduce test duration and improve
diagnostic ability.
As a scanning ophthalmoscope, Compass allows continuous retinal monitoring during peri-
metry and it obtains high-quality images of the central 30° of the retina, with a satisfactory
view of optic nerve head, RNFL and retina in 65% of cases. It is anticipated that the percentage
of patients who had inadequate color images could be reduced in the next version of
the instrument.
The possibility of obtaining images of the posterior pole has several potential advantages:
1. Direct comparison of the optic disc with the perimetric results; which will improve the diag-
nostic accuracy in those cases with an otherwise normal optic disc.
2. The possibility of an assessment of eventual retinal diseases; this will explain an abnormal
test result in patients with a normal optic disc (e.g. myopic atrophy, diabetic retinopathy,
macular degeneration, etc.).
3. The possibility of assessing the RNFL and searching for agreement with the perimetric test
results (“structure-function relationship”). The ability to image the posterior pole might
help to develop a “guided” grid to enhance the diagnostic capability of the
functional assessment.
In conclusion, this pilot study explored the characteristics of Compass. We found that, as a
perimeter, the instrument had a performance overall similar to HFA; yet, the eye tracker re-
duced the measurement “noise” and improved data repeatability. As a scanning ophthalmo-
scope, the instrument provided high-quality images in about 70% of patients, thus allowing a
better evaluation of the functional and structural aspects of disease.
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